PYC PYC Therapeutics takes Polycystic Kidney Disease drug to human trials PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts in the kidneys to human trials. Fouad Haidar 7 days ago ASX News Healthcare Biotechnology
PAR Paradigm Biopharma on track to US Phase III osteo program Paradigm Biopharma has announced its completion of a submission to the US FDA to progress to Phase III of its osteoarthritis 'program.' Jonathon Davidson 19 Apr 2024 10:14 (AEST) ASX News Healthcare Biotechnology
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection Telix Pharmaceuticals has been granted Fast Track designation by the FDA for its brain cancer imaging software; TLX101-CDx Fouad Haidar 16 Apr 2024 12:42 (AEST) ASX News Healthcare Biotechnology
IMU Imugene expands study for bile tract cancer patients Imugene will be expanding its trial to treat gastrointestinal cancers - including bile tract cancer - and is enrolling ten more patients for this purpose. Caroline Smith 15 Apr 2024 10:45 (AEST) ASX News Healthcare Biotechnology
AVH AVITA Medical drops revenue forecast for Q1 AVITA Medical (ASX:AVH) provided an update on its anticipated revenue for Q1 2024 - and has now downgraded its commercial revenue guidance for the quarter Fouad Haidar 12 Apr 2024 09:07 (AEST) ASX News Healthcare Biotechnology
TLX Telix Pharmaceuticals finalises acquisition of IsoTherapeutics Telix Pharmaceuticals (ASX:TLX) has acquired one of its service suppliers - IsoTherapeutics Group - in a deal worth more than A$20 million. Fouad Haidar 09 Apr 2024 10:42 (AEST) ASX 200 Healthcare Biotechnology
PEB Pacific Edge sees steady Cxbladder test results despite headwinds Pacific Edge has posted steady growth in tests for its Cxbladder product, despite some corporate headwinds including a smaller sales force. Caroline Smith 09 Apr 2024 09:38 (AEST) ASX News Healthcare Biotechnology
IMU Imugene picks up new virotherapy patent in China Imugene (ASX:IMU) has announced its receipt of a new patent in China, Asia's largest pharmaceutical market. Jonathon Davidson 04 Apr 2024 10:40 (AEDT) ASX News Healthcare Biotechnology
ATX Amplia Therapeutics takes step up in pancreatic cancer treatment Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful completion of phase 1b of the trial Fouad Haidar 27 Mar 2024 16:11 (AEDT) ASX News Healthcare Biotechnology
CYP Cynata wins EU ethics approval for phase 2 Trial of CYP-001 Cynata Therapeutics has been given EU regulatory and ethics approval for phase 2 Trial of its latest development 'CYP-001' Fouad Haidar 20 Mar 2024 10:44 (AEDT) ASX News Healthcare Biotechnology
MSB Mesoblast (ASX:MSB) completes $97M funding round heading into Q2 Mesoblast (ASX:MSB) has completed its pro-rata accelerated non-renounceable entitlement offer, launched on December 4, 2023. Keely Lynch 14 Mar 2024 13:59 (AEDT) ASX News Healthcare Biotechnology
MSB Mesoblast (ASX:MSB) gains FDA approval to fast-track Revascor in end-stage heart failure Mesoblast (ASX:MSB) has received U.S. FDA approval to accelerate rexlemestrocel-L (Revascor) for patients with end-stage ischemic heart failure and reduced ejection fraction (HFrEF) with a left ventricular assist device (LVAD). Keely Lynch 11 Mar 2024 12:12 (AEDT) ASX News Healthcare Biotechnology
RAC Race Oncology flags bisantrene "anticancer" properties in animals Race Oncology (ASX:RAC) presented some major advancements in the potential treatment of Acute Myeloid Leukemia (AML) Fouad Haidar 06 Mar 2024 11:25 (AEDT) ASX News Healthcare Biotechnology